True North Therapeutics

Antibodies that selectively targets the Classical pathway of the Complement system to treat rare diseases.

placeSan Francisco, California, United States calendar_todayFounded 2013 groups18 employees language truenorthrx.com

Registered entities

Investor mix

15 investors on record; lead investors include HBM Healthcare Investments, Redmile Group.

Investor typeCountShare
Venture capital960%
Bank & private debt17%
Other / undisclosed533%
Coming soon